P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2007

Features

Commentary

Consumer-Directed Health Plans: Where Are We Now?

Although several years have passed since health savings accounts became available to Americans, the number of enrollees has remained relatively low. This article explores some of the pitfalls of the plans and the reluctance of the public to climb aboard.
Miriam Reisman

P&T Around the world

Lessons Learned from a Global Sentinel Event: Priorix Vaccine Returns to Vietnam

The authors present an update to an earlier P&T article on the embargo of Priorix measles–mumps–rubella vaccine after a deadly health scare in Ho Chi Minh City.
Peter Teichman, MD, and Nguyen Tri Doan, MD

Considerations Associated with Therapeutic Interchange within the Fluoroquinolone Class of Antimicrobials

The author discusses the procedures, safeguards, and costs involved when less expensive agents replace preferred drugs in the same pharmacological class.
Robert P. Rapp, PharmD, FCCP

NSAID Usage: Impact of Safety Data and Product Withdrawals on Prescribing Trends

The authors describe the changes in the prescribing patterns for NSAIDs that resulted when valdecoxib (Bextra) and rofecoxib (Vioxx) were withdrawn from the market.
Molly T. Vogt, PhD, Bethany Fedutes-Henderson, PharmD, Amit Duggal, PharmD, MPH, Nicole T. Ansani, PharmD, John Gillespie, MD, and Terence Starz, MD

Book Review

Miracle Medicines: Seven Lifesaving Drugs and the People Who Created Them

Author: Robert L. Shook
Reviewed by Burton Orland, BS, RPh

Pharmaceutical Approval Update

Sitagliptin/metformin (Janumet) for diabetes, lapatinib (Tykerb) for HER-2–positive breast cancer, and protein C concentrate powder (Ceprotin) for venous disorders are reviewed.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

Consumer Engagement

David Nash, MD, MBA, reports on the results of a BlueCross BlueShield survey on how consumers use the Internet to obtain information about medical treatments.
David B. Nash, MD, MBA

Medication Errors

Nix the Quick Fix: Adopting New Drug Protocols Requires Groundwork

Matthew Grissinger, RPh, FASCP, explains the potential problems that can result when new medication protocols are implemented too quickly.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Congress Tries to Strengthen Drug-Testing Laws for Children

Stephen Barlas discusses forthcoming changes to two laws calling for pediatric drug-testing trials.
Stephen Barlas

New Drugs/Drug News

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Dabigatran (Rendix): A Promising New Oral Direct Thrombin Inhibitor

Dr. Paris Abrams and Dr. Nino Marzella review dabigatran (Rendix), a direct thrombin inhibitor.
Paris Abrams, PharmD, and Nino Marzella, BS, PharmD